Parathyroid disorders.
Disorders of the parathyroid glands most commonly present with abnormalities of serum calcium. Patients with primary hyperparathyroidism, the most common cause of hypercalcemia in outpatients, are often asymptomatic or may have bone disease, nephrolithiasis, or neuromuscular symptoms. Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
Department of Family Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. Thomas.c.michels@us.army.mil
Thomas C
TC
Michels
Kevin M
KM
Kelly
D015502:Absorptiometry, Photon; D058070:Asymptomatic Diseases; D001851:Bone Diseases, Metabolic / Q000209:etiology; D002117:Calcitriol / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D049950:Hyperparathyroidism, Primary / Q000175:diagnosis / Q000628:therapy; D006962:Hyperparathyroidism, Secondary / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006996:Hypocalcemia / Q000209:etiology; D007011:Hypoparathyroidism / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010279:Parathyroid Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D051436:Renal Insufficiency, Chronic / Q000150:complications
D002117:Calcitriol